Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) General Information
Description
Provider of muscular dystrophy therapy services based in Boulder, Colorado. The company specializes in investigational therapy for becker and duchenne, clinical trials of sildenafil in becker and duchenne are ongoing, and to preserve and protect fast muscle fibers.
Contact Information
Corporate Office
- Boulder, CO
- United States
Corporate Office
- Boulder, CO
- United States
Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) FAQs
-
Where is Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) headquartered?
Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) is headquartered in Boulder, CO.
-
What industry is Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) in?
Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business)’s primary industry is Laboratory Services (Healthcare).
-
Is Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) a private or public company?
Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) is a Private company.
-
What is the current valuation of Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business)?
The current valuation of Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) is .
-
What is Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business)’s current revenue?
The current revenue for Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) is .
-
Who are Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business)’s investors?
Edgewise Therapeutics has invested in Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business).
-
When was Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) acquired?
Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) was acquired on 01-Jun-2026.
-
Who acquired Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business)?
Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) was acquired by Servier.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process